Entresto 24 MG-26 MG tablet 180S
Ended Awarded Last action
- Contract number
- SPE2DR26F9HS1
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $15,878
Award facts
- Contract value 100% obligated
- $15,878.30 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $15,878.30 to AmerisourceBergen Drug Corp for the supply of Entresto 24 mg-26 mg tablets (180-count units) on December 29, 2025, with completion scheduled for December 30, 2025. This is a firm fixed-price delivery order with no set-aside designation, awarded competitively to the pharmaceutical distributor's Conshohocken, Pennsylvania location. The award represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a ceiling value of $999,999,999 and runs through December 2026. This prime IDC serves as a comprehensive global pharmaceutical support vehicle enabling the supplier to deliver a broad range of medications and medical supplies to military healthcare programs worldwide.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider headquartered in Conshohocken, Pennsylvania, maintains an extensive federal contract portfolio focused on military and veteran healthcare systems. The company's federal awards demonstrate consistent capability to compete and deliver across diverse pharmaceutical product categories, from brand-name medications to generic drugs, vaccines, and specialized medical supplies. Entresto is a heart failure medication, reflecting the company's role in supplying critical therapeutic agents to Defense Health Agency, U.S. Coast Guard, and other federal healthcare customers through its flexible and comprehensive contract vehicles with DLA.
Quick answers
Who was awarded contract SPE2DR26F9HS1?
SPE2DR26F9HS1 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 29, 2025.
How much is contract SPE2DR26F9HS1 worth?
The government has obligated $15,878 on SPE2DR26F9HS1.
Is contract SPE2DR26F9HS1 an order under another contract?
Yes. SPE2DR26F9HS1 is a delivery order under SPE2DR25D2206, an indefinite delivery contract.
Was contract SPE2DR26F9HS1 competed?
The extent of competition for SPE2DR26F9HS1 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award